ECMO bleeding mystery: new study probes hidden clotting defect
NCT ID NCT03070912
First seen Jan 08, 2026 · Last updated May 09, 2026 · Updated 19 times
Summary
This study observed 257 emergency patients on ECMO (a heart-lung machine) to understand why many experience serious bleeding. Researchers checked for defects in von Willebrand factor, a protein that helps blood clot. The goal was to see how often bleeding happens and if it's linked to these clotting problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH ARRAS
Arras, France
-
CH Boulogne
Boulogne-sur-Mer, France
-
CH DOUAI
Douai, France
-
CH Dunkerque
Dunkirk, 59385, France
-
Ch Tourcoing
Tourcoing, France
-
Ch Valenciennes
Valenciennes, France
-
Hôpital Cardiologie, CHU
Lille, France
Conditions
Explore the condition pages connected to this study.